Pharma Foods International Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802310007
JPY
683.00
-17 (-2.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jan'26
Oct'25
Jul'25
Apr'25
Jan'25
Oct'24
Jul'24
Net Sales
16,729.00
15,712.00
18,443.00
16,960.00
15,261.00
14,596.00
14,976.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,729.00
15,712.00
18,443.00
16,960.00
15,261.00
14,596.00
14,976.00
Raw Material Cost
3,071.00
3,091.00
3,596.00
3,528.00
2,892.00
2,713.00
3,544.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.00
25.00
23.00
27.00
17.00
24.00
18.00
Selling and Distribution Expenses
13,149.00
14,800.00
11,822.00
13,951.00
12,327.00
10,663.00
9,312.00
Other Expenses
32.50
30.70
41.60
29.50
28.40
31.30
25.50
Total Expenditure (Excl Depreciation)
16,579.00
18,223.00
15,857.00
17,801.00
15,520.00
13,713.00
13,129.00
Operating Profit (PBDIT) excl Other Income
150
-2511
2586
-841
-259
883
1847
Other Income
-27.00
-106.00
225.00
-10.00
32.00
29.00
95.00
Operating Profit (PBDIT)
301.00
-2,451.00
3,026.00
-650.00
-37.00
1,091.00
2,375.00
Interest
34.00
25.00
23.00
27.00
17.00
24.00
18.00
Exceptional Items
0.00
0.00
-118.00
0.00
0.00
0.00
-123.00
Gross Profit (PBDT)
13,658.00
12,621.00
14,847.00
13,432.00
12,369.00
11,883.00
11,432.00
Depreciation
178.00
166.00
215.00
201.00
190.00
179.00
433.00
Profit Before Tax
89.00
-2,640.00
2,665.00
-876.00
-243.00
888.00
1,800.00
Tax
23.00
-749.00
1,174.00
477.00
-112.00
527.00
451.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
67.00
-1,891.00
1,491.00
-1,352.00
-131.00
360.00
1,349.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
67.00
-1,891.00
1,491.00
-1,352.00
-131.00
360.00
1,349.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
67.00
-1,891.00
1,491.00
-1,352.00
-131.00
360.00
1,349.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
9,771.00
9,379.00
11,547.00
10,239.00
12,048.00
11,479.00
11,585.00
Earnings per share (EPS)
2.31
-65.5
51.64
-46.53
-4.51
12.82
48.05
Diluted Earnings per share
2.31
-65.5
51.64
-46.53
-4.51
12.82
48.05
Operating Profit Margin (Excl OI)
0.9%
-15.98%
14.02%
-4.96%
-1.7%
6.05%
12.33%
Gross Profit Margin
1.6%
-15.75%
15.62%
-3.98%
-0.35%
7.31%
14.91%
PAT Margin
0.4%
-12.04%
8.08%
-7.97%
-0.86%
2.47%
9.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jan 2026 is 6.47% vs -14.81% in Oct 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jan 2026 is 103.54% vs -226.83% in Oct 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jan 2026 is 113.99% vs -183.72% in Oct 2025

stock-summary

Interest

QoQ Growth in quarter ended Jan 2026 is 36.00% vs 8.70% in Oct 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jan 2026 has improved from Oct 2025

Compare Quarterly Results Of Pharma Foods International Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,729.00
13,284.00
3,445.00
25.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,729.00
13,284.00
3,445.00
25.93%
Raw Material Cost
3,071.00
4,339.00
-1,268.00
-29.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
34.00
116.00
-82.00
-70.69%
Selling and Distribution Expenses
13,149.00
8,441.00
4,708.00
55.78%
Other Expenses
32.50
-11.60
44.10
380.17%
Total Expenditure (Excl Depreciation)
16,579.00
12,780.00
3,799.00
29.73%
Operating Profit (PBDIT) excl Other Income
150.00
504.00
-354.00
-70.24%
Other Income
-27.00
-167.00
140.00
83.83%
Operating Profit (PBDIT)
301.00
1,201.00
-900.00
-74.94%
Interest
34.00
116.00
-82.00
-70.69%
Exceptional Items
0.00
-215.00
215.00
100.00%
Gross Profit (PBDT)
13,658.00
8,945.00
4,713.00
52.69%
Depreciation
178.00
864.00
-686.00
-79.40%
Profit Before Tax
89.00
8.00
81.00
1,012.50%
Tax
23.00
221.00
-198.00
-89.59%
Provisions and contingencies
0
0
0.00
Profit After Tax
67.00
-424.00
491.00
115.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
67.00
-424.00
491.00
115.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
211.00
-211.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.00
-213.00
280.00
131.46%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
9,771.00
30,957.00
-21,186.00
-68.44%
Earnings per share (EPS)
2.31
-3.11
5.42
174.28%
Diluted Earnings per share
2.31
-3.11
5.42
174.28%
Operating Profit Margin (Excl OI)
0.90%
3.79%
0.00
-2.89%
Gross Profit Margin
1.60%
6.56%
0.00
-4.96%
PAT Margin
0.40%
-3.19%
0.00
3.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,672.90 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 6.47% vs -14.81% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 9.62% vs -1.61% in Jan 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.70 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 103.54% vs -226.83% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 151.15% vs -127.18% in Jan 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.80 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 113.99% vs -183.72% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 575.36% vs -106.23% in Jan 2025

Quarterly - Interest
Interest 3.40 Million
in Jan 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jan 2026 is 36.00% vs 8.70% in Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 is 100.00% vs 30.77% in Jan 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.90%
in Jan 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jan 2026 has improved from Oct 2025

stock-summary

YoY Growth in quarter ended Jan 2026 has improved from Jan 2025